Effect of Perioperative Glutamine Supplementation on Acute Kidney Injury in Infants Undergoing Elective Cardiac Surgery: A Randomized Controlled Trial

Objective: Acute kidney injury (AKI) is a frequent and serious complication in infants after cardiac surgery. Glutamine (GLN), a conditionally essential amino acid, has demonstrated renoprotective potential in animal models and has been shown to attenuate biomarkers of kidney damage in high-risk patients undergoing cardiac surgery. However, whether these renoprotective benefits extend to pediatric patients remains unknown. Methods: We conducted a single-center, randomized, double-blind, placebo-controlled trial in infants and young children younger than 3 years undergoing cardiac surgery with cardiopulmonary bypass. Ninety-four patients were randomly assigned to receive intravenous alanyl-glutamine (0.4 g/kg/day, n = 47) or 0.9% saline placebo (n = 47), administered from anesthesia induction and continued for 4 consecutive days (the day of surgery and the first 3 postoperative days). The primary outcome was the incidence of AKI within 72 h postoperatively, defined according to the KDIGO criteria. Secondary outcomes included the requirement for peritoneal dialysis (PD), diuretic use, serum creatinine (Scr), neutrophil gelatinase-associated lipocalin (NGAL), cystatin C, procalcitonin, and the lengths of ICU and hospital stay. Results: The incidence of KDIGO-defined AKI was lower in the GLN group than in the control group (14.9% vs. 40.4%; p = 0.010). Among the prespecified secondary outcomes, the requirement for PD (0% vs. 12.8%; p = 0.026) and diuretic use (6.4% vs. 23.4%; p = 0.040) were also lower in the GLN group. Postoperative NGAL concentrations were lower in the GLN group at 24, 48, and 72 h (p < 0.050 for each time point). No significant differences were observed in the lengths of ICU or hospital stay. Conclusions: In this single-center trial, perioperative GLN supplementation was associated with a lower incidence of postoperative AKI, a lower requirement for PD, and less diuretic use in infants undergoing elective cardiac surgery. These exploratory findings support a possible renoprotective role for GLN in this high-risk population but require confirmation in larger multicenter trials before adoption into clinical practice.

Authors

Institutions

Publication Details

Journal
Nutrients
Published
2026-11-19
DOI
https://doi.org/10.3390/nu18223859
Primary Topic
Acute Kidney Injury Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effect of Perioperative Glutamine Supplementation on Acute Kidney Injury in Infants Undergoing Elective Cardiac Surgery: A Randomized Controlled Trial

Wenjun Qin, Haifa Hong, Li Wang, Xiaobing Li et al.
Nutrients
Acute Kidney Injury Research
article

Effect of Perioperative Glutamine Supplementation on Acute Kidney Injury in Infants Undergoing Elective Cardiac Surgery: A Randomized Controlled Trial

Wenjun Qin, Haifa Hong, Li Wang, Xiaobing Li, Jia Li
article en

Abstract

Objective: Acute kidney injury (AKI) is a frequent and serious complication in infants after cardiac surgery. Glutamine (GLN), a conditionally essential amino acid, has demonstrated renoprotective potential in animal models and has been shown to attenuate biomarkers of kidney damage in high-risk patients undergoing cardiac surgery. However, whether these renoprotective benefits extend to pediatric patients remains unknown. Methods: We conducted a single-center, randomized, double-blind, placebo-controlled trial in infants and young children younger than 3 years undergoing cardiac surgery with cardiopulmonary bypass. Ninety-four patients were randomly assigned to receive intravenous alanyl-glutamine (0.4 g/kg/day, n = 47) or 0.9% saline placebo (n = 47), administered from anesthesia induction and continued for 4 consecutive days (the day of surgery and the first 3 postoperative days). The primary outcome was the incidence of AKI within 72 h postoperatively, defined according to the KDIGO criteria. Secondary outcomes included the requirement for peritoneal dialysis (PD), diuretic use, serum creatinine (Scr), neutrophil gelatinase-associated lipocalin (NGAL), cystatin C, procalcitonin, and the lengths of ICU and hospital stay. Results: The incidence of KDIGO-defined AKI was lower in the GLN group than in the control group (14.9% vs. 40.4%; p = 0.010). Among the prespecified secondary outcomes, the requirement for PD (0% vs. 12.8%; p = 0.026) and diuretic use (6.4% vs. 23.4%; p = 0.040) were also lower in the GLN group. Postoperative NGAL concentrations were lower in the GLN group at 24, 48, and 72 h (p < 0.050 for each time point). No significant differences were observed in the lengths of ICU or hospital stay. Conclusions: In this single-center trial, perioperative GLN supplementation was associated with a lower incidence of postoperative AKI, a lower requirement for PD, and less diuretic use in infants undergoing elective cardiac surgery. These exploratory findings support a possible renoprotective role for GLN in this high-risk population but require confirmation in larger multicenter trials before adoption into clinical practice.

NutrientsVol. 18(22)
Shanghai Children's Hospital (CN)
Acute Kidney Injury Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon